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Nager syndrome, first describedmore than 60 years ago, is the archetype of a class of disorders called the acrofacial dysostoses, which are
characterized by craniofacial and limb malformations. Despite intensive efforts, no gene for Nager syndrome has yet been identified. In
an international collaboration, FORGE Canada and the National Institutes of Health Centers for Mendelian Genomics used exome
sequencing as a discovery tool and found that mutations in SF3B4, a component of the U2 pre-mRNA spliceosomal complex, cause
Nager syndrome. After Sanger sequencing of SF3B4 in a validation cohort, 20 of 35 (57%) families affected by Nager syndrome had 1
of 18 different mutations, nearly all of which were frameshifts. These results suggest that most cases of Nager syndrome are caused
by haploinsufficiency of SF3B4. Our findings addNager syndrome to a growing list of disorders caused bymutations in genes that encode
major components of the spliceosome and also highlight the synergistic potential of international collaboration when exome
sequencing is applied in the search for genes responsible for rare Mendelian phenotypes.Nager syndrome (MIM 154400), first described by Nager
and De Reynier in 1948,1 is the prototype for a group of
disorders collectively referred to as the acrofacial dysosto-
ses (AFDs), which are characterized by malformations of
the craniofacial skeleton and the limbs (Figure 1).2,3 The
major facial features of Nager syndrome include down-
slanted palpebral fissures, midface retrusion, and micro-
gnathia, the latter of which often requires the placement
of a tracheostomy in early childhood. Limb defects
typically involve the anterior (i.e., radial) elements of
the upper limbs and manifest as small or absent thumbs,
triphalangeal thumbs, radial hypoplasia or aplasia, and
radioulnar synostosis. Phocomelia of the upper limbs
and, occasionally, lower-limb defects have also been re-
ported.4 The presence of anterior upper-limb defects as
opposed to posterior upper-limb defects and the typical
lack of lower-limb involvement distinguishes Nager
syndrome from Miller syndrome (MIM 263750), another
rare AFD.5 However, distinguishing Nager syndrome
from other AFDs, including Miller syndrome, can be chal-
lenging, and there are numerous reports of individuals
and families that have been difficult for researchers to
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The AmNager syndrome is rare, and, to date, fewer than 100
cases have been reported.6 Most cases are sporadic, but
both autosomal-dominant7–9 and autosomal-reces-
sive10,11 segregation have been reported. This has led to
the widespread speculation that Nager syndrome is genet-
ically heterogeneous. The rarity of this syndrome, which
typically occurs as a simplex case, and the different modes
of inheritance have made identification of the causal
gene(s) intractable to conventional gene-discovery
approaches. Given the phenotypic overlap between Nager
and Miller syndromes and given our recent finding that
Miller syndrome is caused by mutations in DHODH
(MIM 126064),12 we and others suspected that the disor-
ders might be allelic or caused by genes in the pyrimidine
biosynthetic pathway. However, screening of families
affected by Nager syndrome (n > 12) did not reveal any
mutations in these genes (Bamshad et al., unpublished
data).
To identify a gene for Nager syndrome, investigators at
the University of Calgary as part of the FORGE (Finding
of Rare Disease Genes) Canada Consortium and investiga-
tors at the University of Washington (UW) as one of the
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Figure 1. Characteristic Craniofacial and Limb Malformation in Individuals with Nager Syndrome and SF3B4 Mutations
Typical features of the face include downslanted palpepral fissures, malar flattening, and variable external ear malformations. Hand
abnormalities include small thumbs and, in some cases, upper-limb reduction defects (C-1). Labels correspond to those in Tables 1–3,
where a detailed description of each individual is provided.Genomics independently performed exome sequencing.13
Between both institutions, a total of 35 independent
families (a total of 41 affected individuals) afflicted with
Nager syndrome were available for study (Figure 1 and
Tables 1–3). These families consisted of 28 simplex
families, including one in which the parents were consan-
guineous, and seven multiplex families: two with mother-
to-son transmissions, one with a father-to-daughter trans-
mission, two with mother-to-daughter transmissions, one
consisting of an affected mother and her two affected
sons, and one with a pair of affected monozygotic twins
(Table S1, available online). An experienced clinical genet-
icist was responsible for each diagnosis of Nager syndrome,
each participant provided informed consent, and studies
were approved by the institutional review boards of the
University of Calgary, the University of Washington, and
Seattle Children’s Hospital.
Exome sequencing of five independent simplex cases
was performed by the FORGE Canada team at the McGill
University and Genome Que´bec Innovation Centre
according to the manufacturer’s (Illumina) standard proto-
cols for the Agilent SureSelect 50 Mb exome enrichment
kit, and captured targets were sequenced on a HiSeq2000
sequencer. Reads were aligned to a human reference
(hg19) with the Burrows-Wheeler Aligner (BWA),14 and
indel realignment was performed with the GATK.15 Dupli-926 The American Journal of Human Genetics 90, 925–933, May 4, 2cate reads were then marked with Picard and excluded
from downstream analyses. Coverage of consensus coding
sequence (CCDS) bases was assessed with GATK, which
showed that all samples had>90% coverage of CCDS bases
and a depth of at least 103. For each sample, single-nucle-
otide variants (SNVs) and short insertions and deletions
(indels) were called with the use of SAMtools pileup16
with the extended base alignment quality (BAQ) adjust-
ment (-E), and they were then quality filtered so that at
least 20% of the reads supported the variant call. We anno-
tated variants by using both Annovar17 and custom scripts
to identify whether they affected protein-coding sequence
and whether they were previously observed in dbSNP132,
1000 Genomes Project data (Nov. 2011), or ~300 exomes
previously obtained at the center.
At the University of Washington, exome sequencing
was performed on four simplex cases with Nager syndrome
and three unrelated individuals from multiplex families;
these three latter individuals included one affected child
born to an affected parent and two affected parents, each
of whom had at least one affected child. In brief, we per-
formed exome capture on a shotgun library created from
1 mg of genomic DNA by using the ~62 Mb target from
Roche Nimblegen SeqCap EZ v2.0 (~300,000 exons and
flanking sequence). Exome capture was followed by
massively parallel sequencing on a HiSeq 2000 sequencer012
Table 1. Clinical Features of Nager-Syndrome Patients A-1 through H-1 with SF3B4 Mutations
A-1 B-1 C-1 D-1 E-1 F-1 F-2 G-1 H-1
Inheritance sporadic sporadic sporadic sporadic sporadic sporadic;
father
of F-2
AD;
daughter
sporadic sporadic
Gender female female male female female male female female female
Age (years) 5 4 2 24 23 38 1 12 5
Downslanted
palpebral fissures
þ þ þ þ þ þ ND – ND
Absent lower
eyelashes
sparse ND ND þ – ND ND – þ
Midface retrusion þ þ þ þ þ ND ND ND ND
Micrognathia þ þ þ þ þ þ þ þ þ
Ankylosis of
TM joint
ND ND – – ND ND þ ND
Abnormal palate cleft soft
palate
– cleft – – – cleft cleft cleft
Tracheotomy – þ þ þ – – þ þ ND
Abnormal ears þ þ þ þ mild – ND ND ND
Hearing loss þ þ þ – þ þ þ
Radial ray
abnormality
– þ absent
bilateral
– – ND ND þ þ
Abnormal
thumbs
stiff bilateral þ absent
bilateral
small right
thumb and
slender left
thumb
hypoplasia ND ND absent
bilateral
þ
Radioulnar
synostosis
bilateral þ – unilateral bilateral þ þ þ ND
Development normal normal delayed normal speech
delay
only
normal ND ND ND
Other
malformations
– VSD and
diaphragmatic
hernia
fused 1st and
2nd right
metacarpals
and bilateral
foot deformities
abnormal teeth,
partial absence
of left fingers 3–5,
slender haluces,
and hallux valgus
asymmetric
face, VPI,
and cervical
ribs
valgus
laxity
of knees
and ankles
subglottic
stenosis
– –
SF3B4 mutation c.1A>Ga c.864delTa c.1147delCa c.913þ1G>A c.1148dupA c.1A>Gb c.1A>Gb c.827dupC c.1232delC
The following abbreviations are used: TM, temporomandibular; ND, not determined; VPI, velopharyngeal insufficiency; AD, autosomal dominant; and VSD, ven-
triculoseptal defect.
aConfirmed de novo mutation.
bConfirmed familial mutation.(Illumina). BAM files were also aligned to a human refer-
ence (hg19) with the BWA,14 and duplicate reads were
removed with Picard. Variant detection and genotyping
were performed with the UnifiedGenotyper tool from
GATK (refv1.529). Exome completion was defined as
having >90% of the exome target at >83 coverage. Typi-
cally, this requires that the target have a mean coverage
of 60–803. An automated pipeline, the SeattleSeq Annota-
tion Server, was used for the annotation of variants. Novel
variants are defined as those not observed in dbSNP
version 134 or in 1,200 exomes drawn from a subset of
samples from the National Heart, Lung, and Blood Insti-
tute (NHLBI) Exome Sequencing Project (ESP).The AmBecause the mode of inheritance of Nager syndrome for
most cases was unclear, discrete filtering for novel variants
in the same gene shared among cases was performed under
both autosomal-dominant and autosomal-recessive
models. In neither cohort was a gene found to be shared
among all the unrelated Nager-syndrome cases under a
recessive mode of inheritance, i.e., those who were com-
pound heterozygous for two novel variants or homozy-
gous for a rare novel variant. This suggested that if Nager
syndrome were an autosomal-recessive disorder, it would
have high locus heterogeneity. Under an autosomal-domi-
nant model, one gene, TTN (MIM 188840), in the FORGE
cohort and two genes, MUC12 (MIM 604609) and MUC16erican Journal of Human Genetics 90, 925–933, May 4, 2012 927
Table 2. Clinical Features of Nager-Syndrome Patients I-1 through M-3 with SF3B4 Mutations
I-1 J-1 J-2 K-1 L-1 M-1 M-2 M-3 N-1
Inheritance sporadic AD;
son
sporadic;
mother
of J-1
sporadic sporadic sporadic;
father of
M-2, M-3
AD; son AD; son Sporadic
Gender female male female female female female male male female
Age (years) 28 17 56 15 4 49 20 17 13
Downslanted
palpebral
fissures
þ þ þ ND þ þ þ þ þ
Absent lower
eyelashes
sparse þ – ND þ ND sparse þ þ
Midface
retrusion
þ þ ND ND ND þ þ þ þ
Micrognathia þ þ þ ND þ – þ þ þ
Ankylosis
of TM joint
ND ND ND ND ND ND ND ND þ
Abnormal
palate
– ND ND ND – cleft – þ high arched;
cleft soft palate
Tracheotomy ND þ ND ND – – þ – þ
Abnormal ears þ þ ND ND – cupped cupped;
narrow canals
cupped;
narrow canals
þ
Hearing loss þ þ ND ND þ þ þ þ þ
Radial ray
abnormality
ND ND ND ND þ – – – –
Abnormal
thumbs
small þ ND ND absent left
thumb and
fused right DIP
small absent right
thumb and
small left thumb
small right
thumb
compared
to left
absent right
thumb and
small and
stiff left thumb
Radioulnar
synostosis
ND ND ND ND þ – right > left left þ
Development ND normal ND ND ND ND delayed speech
and fine motor
delayed delayed
Other
malformations
– – – – limited ROM in all
extremities at birth,
arachnodactly, and
small 5th fingers
– short stature
(3–5%),
dacryostenosis,
and small first
toes and first
metatarsals
dacryostenosis,
short first
metatarsals,
and sandal gap
limited ROM in
elbows and shoulders,
camptodactyly,
left clubfoot, renal
abnormalities, VSD,
and dacryostenosis
SF3B4
mutation
c.1060dupCa c.1A>Gb c.1A>Gb c.452C>A c.836_837
insGGGTATGa
c.1199delCb c.1199delCb c.1199delCb c.88delT
The following abbreviations are used: TM, temporomandibular; ND, not determined; AD, autosomal dominant; ROM, range of motion; VSD, ventriculoseptal
defect; and DIP, distal interphalangeal joint.
aConfirmed de novo mutation.
bConfirmed familial mutation.(MIM 606154), in the UW cohort had novel variants
shared among all unrelated cases. These large genes are
frequent sources of false-positive calls and were excluded
from consideration.
In both cohorts, several genes had novel or rare variants
shared among two, three, or four cases with Nager
syndrome, and prioritizing these candidates was not
possible. We further filtered the gene list from the FORGE
cohort by assigning higher priority to variants predicted
to have a greater deleterious impact on protein function
(i.e., nonsense, frameshift, initiation-codon, and splice-928 The American Journal of Human Genetics 90, 925–933, May 4, 2site variants) and then reanalyzed the list. A single gene,
SF3B4 (MIM 605593), which encodes a component of
the U2SNP of the major spliceosome, was found to have
different novel variants in two unrelated cases of Nager
syndrome (Table S2). In the UW cohort, subsequent
discrete filtering limited to only genes with novel variants
shared among the three familial-Nager-syndrome cases
identified three candidate genes, including SF3B4. In two
of these cases, the variant identified (c.1A>G [p.M1?])
was identical to one of the SF3B4 variants found in
the FORGE cohort. Sanger sequencing subsequently012
Table 3. Clinical Features of Nager-Syndrome Patients O-1 through T-1 with SF3B4 Mutations
O-1 O-2 P-1 Q-1 R-1 R-2 S-1 T-1
Inheritance AD; son sporadic;
mother
of O-1
sporadic sporadic AD;
daughter
AD;
mother
sporadic sporadic
Gender male female male female female female female male
Age (years) 1 28 2 1 7 ND 4 2
Downslanted
palpebral fissures
þ þ þ ND þ ND þ þ
Absent lower
eyelashes
ND ND decreased minimal ND ND ND ND
Midface
retrusion
ND ND þ þ þ þ þ þ
Micrognathia þ þ þ þ þ ND þ þ
Ankylosis
of TM joint
ND ND ND ND ND ND ND ND
Abnormal
palate
abnormal
soft palate
abnormal
soft palate
abnormal
soft palate
abnormal
soft palate
þ ND high arched þ
Tracheotomy ND ND ND ND ND ND þ ND
Abnormal ears þ þ þ þ þ ND þ þ
Hearing loss þ þ þ þ þ ND ND þ
Radial ray
abnormality
ND ND þ þ short ND þ þ
Abnormal
thumbs
absent right
thumb and
small left thumb
small proximally
placed
and stiff
absent
bilateral
stiff
bilateral
stiff
bilateral
þ þ
Radioulnar
synostosis
– bilateral right – ND ND ND þ
Development ND ND – ND ND ND ND ID
Other
malformations
– – – hair extension on
cheek, strabismus,
mitral valve prolapse,
and limited ROM
in elbows
– – short stature and
bilateral syndactyly
of the 4th and
5th toes
–
SF3B4
mutation
c.1147dupCa c.1147dupCa c.769delA c.625C>T c.1252_1258del
CTTCGAG
not
tested
c.796dupA c.661_664dup
CCCA
The following abbreviations are used: ID, intellectual disability; TM, temporomandibular; ND, not determined; AD, autosomal dominant; and ROM, range of
motion.
aConfirmed familial mutation.confirmed that all four novel variants were present in
SF3B4 and that the variants were de novo in the FORGE
simplex cases and inherited from an affected parent (one
case) and transmitted to an affected child (one case) in
the UW families.
Further evidence supporting the hypothesis that muta-
tions in SF3B4 cause Nager syndrome was provided by a
recent finding that mutations in EFTUD2 (MIM 603892),
which also encodes a component of the spliceosome, cause
a mandibulofacial dysostosis with microcephaly (MFDM
[MIM 610536]) whose craniofacial findings overlap the
symptoms of Nager syndrome.18 Furthermore, an indi-
vidual had previously been reported to have an unclassifi-
able AFD and a 1q21.2 deletion spanning the region
containing SF3B4.19 Collectively, these results strongly
suggest that mutations in SF3B4 cause Nager syndrome.The AmTo determine the extent to which SF3B4 mutations
explain cases of Nager syndrome, we used Sanger
sequencing to screen SF3B4 in a validation cohort of 23
additional unrelated families affected by Nager syndrome.
We also screened the eight individuals who underwent
exome sequencing but in whom no SF3B4 mutation was
found. Collectively, between the initial study cohort and
our validation studies, SF3B4 mutations were found in
20 of the 35 (57%) families, including five of the seven
families with more than one individual affected by Nager
syndrome. For simplex cases, 15 of 28 (54%) had muta-
tions in SF3B4, and in each of the five simplex cases for
which DNA was available from both parents, the SF3B4
mutation was confirmed to have arisen de novo. No
SF3B4 mutation was identified in the single consanguin-
eous family in our cohort. Overall, 25 out of 41 (61%)erican Journal of Human Genetics 90, 925–933, May 4, 2012 929
Table 4. Summary of SF3B4 Mutations
Family Nucleotide Exon Peptide Inheritance Predicted Effect
A, F, J c.1A>G 1 p.Met1? de novo (A) and familial (F and J) loss of initiator methionine
N c.88delT 2 p.Trp30Glyfs*10 NA frameshift
K c.452C>A 3 p.Ser151* NA nonsense
Q c.625C>T 3 p.Gln209* NA nonsense
T c.661_664dupCCCA 3 p.Asn222Thrfs*265 NA frameshift
P c.769delA 4 p.Ile257Tyrfs*63 NA frameshift
S c.796dupA 4 p.Met266Asnfs*220 NA frameshift
G c.827dupC 4 p.Ser277Ilefs*209 NA frameshift
L c.836_837insGGGTATG 4 p.Thr280Glyfs*208 de novo frameshift
B c.864delT 4 p.His288Glnfs*32 de novo frameshift
D c.913þ1G>A intron 4 NA NA splice
I c.1060dupC 5 p.Arg354Profs*132 de novo frameshift
C c.1147delC 6 p.His383Metfs*75 de novo frameshift
O c.1147dupC 6 p.His383Profs*103 familial frameshift
E c.1148dupA 6 p.His383Glnfs*103 NA frameshift
M c.1199delC 6 p.Pro400Leufs*58 familial frameshift
H c.1232delC 6 p.Pro411Glnfs*47 NA frameshift
R c.1252_1258delCTTCGAG 6 p.Leu418Alafs*38 familiala frameshift
The following abbreviation is used: NA, parental DNAs were unavailable for the confirmation of inheritance.
aMother’s sample was not available for testing.Nager-syndrome-affected individuals in our cohort had
mutations in SF3B4 (Tables 1–3 and Table S1).
A total of 18 unique mutations were identified, and
these include 14 frameshift, two nonsense, one splicing,
and one missense mutation (c.1A>G [p.Met1?]), the last
of which is predicted to abolish the methionine initiation
codon and was the only recurrent (i.e., in three unrelated
families) mutation found (Table 4 and Figure 2). Four of
the Nager-syndrome cases with a SF3B4 variant that was
missed by exome sequencing were found to have indels,
and manual inspection of the BAM files revealed that
they all occurred in regions with relatively low coverage
(i.e., <83). None of the SF3B4 missense, nonsense, or
splice-site mutations identified in the participants were
found in >10,800 chromosomes sequenced as part of the
NHLBI-ESP (see Web Resources). Indeed, only 22 rare
(minor allele frequency of <0.5%) SNVs, six of which
were missense variants, were observed in this ESP dataset.
Accordingly, SF3B4 is highly conserved, and most new
mutations are likely to be selected against, consistent
with the observation that most of the mutations we iden-
tified are de novo events.
All of the SF3B4 variants identified are predicted to
encode a truncated polypeptide chain or an elongated
polypeptide with an altered 30 end in the absence of
nonsense-mediated RNA decay (Figure 2C). Together
with the observation that a deletion of chromosomal930 The American Journal of Human Genetics 90, 925–933, May 4, 2region 1q12–q21.1 or q21.3, which encompasses SF3B4,
has been reported in a child with characteristics of Nager
syndrome,19 our findings suggest that Nager syndrome
probably results from haploinsufficiency of SF3B4.
SF3B4 encodes SAP49, a spliceosomal protein that is one
of seven core proteins of the mammalian SF3B complex
and is highly conserved with two RNA recognition motifs
(RRMs) followed by a proline-glycine rich domain (Fig-
ure 2B). During assembly of the U2SNP prespliceosomal
complex, SAP49 binds to the pre-mRNA just upstream of
the branch point sequence but also interacts specifically
with other U2 snRNPS, particularly SAP145, suggesting
that SAP49 plays a crucial role in tethering the U2 snRNP
to the branch site.20
Our discovery adds Nager syndrome to an emerging
group of disorders caused by mutations in genes that
encode subunits of the spliceosome. Mutations in splicing
factors were initially reported in patients with autosomal-
dominant retinitis pigmentosa.21–24 Subsequently, biallelic
mutations in RNU4ATAC (MIM 601428), a component of
the minor spliceosome required for excision of the U12
class of introns, were reported to cause lethal microce-
phalic osteodysplastic primordial dwarfism type I (MIM
210710).25,26 Most recently, mutations in EFTUD2 have
been reported in individuals with MFDM, a disorder with
many features that overlap those of Nager syndrome.18
Although the limbs are typically normal in MFDM, the012
Figure 2. Location of SF3B4 Mutations that Cause Nager Syndrome
(A) Distribution of mutations. Red text indicates an initiator methioninemutation, purple text indicates nonsensemutations, green text
indicates a splice mutation, and black text indicates frameshift mutations.
(B) Domain structure of SAP49. The following abbreviation is used: RRM, RNA recognition motif.
(C) Predicted translational effect of each SF3B4mutation. Dotted lines indicate a deletion, the blue box indicates reference amino acid
sequences, the red bar indicates altered amino acid sequences, and asterisks indicate potential for nonsense-mediated RNA decay.fact that some individuals have thumb abnormalities
suggests that Nager syndrome and MFDM could be
confused with one another.18 To this end, we screened
EFTUD2 in all of the UW cohort Nager-syndrome individ-
uals who did not have mutations in SF3B4, and we identi-
fied a single individual with a novel nonsense mutation
(c.2495C>G [p.Tyr832*]). This mutation affects the amino
acid residue adjacent to an EFTUD2mutation (c.2493C>A
[p.Tyr831*]) found in one family with MFDM.18 In retro-
spect, this individual also had microcephaly, suggesting
that MFDM rather than Nager syndrome is the appropriate
diagnosis.
It is clear that SAP49 and U5-116KD, encoded by
EFTUD2, are critical components of the major spliceo-
some, but their role in the pathogenesis of defects in
craniofacial and limb development is unknown. The
mouse homolog of SF3B4, SAP49 (mSAP49), is highly
conserved and shows broad expression in adult
tissues.27,28 Whole-mount in situ hybridization shows
high expression at day 11 after conception in limbs and
somites, as well as dynamic patterns of expression in the
developing heart.27 These results suggest that mSAP49
expression during development varies in both a time-
and tissue-specific manner. Whereas limb malformations
are frequently seen in Nager syndrome, the fact that only
2 out of 20 (10%) SF3B4-mutation carriers had cardiacThe Amdefects suggests that SF3B4 haploinsufficiency has only
minor effects on human heart development.
Spliceosomes are not only critical for mediating intron
splicing but are also key regulators of alternative
splicing29,30 and, as such, play an important role in the
control of gene-expression pathways. Furthermore, alter-
native splicing of mRNA is a major source of protein
diversity, and tissue-specific alternative splicing further
increases the diverse cellular functions of proteins. Spliceo-
somes might directly regulate developmental genes via the
control of splicing or tissue specificity. Thus, the defects
observed in individuals with Nager syndrome could be
due to aberrant splicing of genes involved in craniofacial
and limb development. However, this hypothesis is not
supported by evidence from sf3b1þ/-heterozygous-null
mice. Isono et al.31 reported that Sf3b1þ/ heterozygous
mice exhibited skeletal malformations concomitant with
ectopic Hox expression. Because polycomb group (PcG)
proteins are required for the stable repression of Hox, Isono
et al. measured the transcript levels for five PcG genes and
three Hox genes.31 Despite Sf3b1 expression levels that
were reduced by half in the sf3b1þ/mice, transcript levels
of the PcG and Hox genes were similar to those of the
controls. Thus, the homeotic transformations in sf3b1þ/
mice appear to be independent of alterations in overall
gene transcription.erican Journal of Human Genetics 90, 925–933, May 4, 2012 931
Further evidence that mutations in SF3B4 might cause
Nager syndrome via a mechanism unrelated to its role in
mediating splicing is provided by studies linking SAP49
to bone morphogenetic protein (BMP) signaling. BMP
proteins are multifunctional growth factors with roles in
early embryogenesis and skeletogenesis. BMP2 and BMP4
are the main sources of BMP signaling in the developing
limbs and also play a critical role in chondrogenesis.32 To
find molecules specific to BMP-mediated signal transduc-
tion, Watanabe et al.33 identified SAP49 by using BMPR-IA,
a BMP receptor, as a bait protein in a yeast two-hybrid
screen. Coimmunoprecipitation and immunoblot analysis
confirmed their interaction inmammalian cells.33 SAP49 is
also found in cell-membrane fractions, and overexpression
of SAP49 inhibits BMP-2-mediated osteogenic and chon-
drocytic differentiation. These findings suggest that
SAP49, in addition to its role in mRNA splicing, might
also specifically inhibit BMP-mediated osteochondral cell
differentiation33
In summary, we applied exome sequencing across 12
unrelated cases to discover that mutations in SF3B4 cause
Nager syndrome and explain ~60% of the cases in our over-
all cohort, including five out of seven multiplex families
and 54% of simplex cases. The clinical characteristics of
individuals with Nager syndrome caused by SF3B4 muta-
tions were indistinguishable from those without SF3B4
mutations. Although partial or whole-gene deletions or
mutations in noncoding regulatory regions of SF3B4might
explain some of the SF3B4 mutation-negative cases in our
cohorts, this observation is strong evidence that Nager
syndrome is genetically heterogeneous. Our findings also
indicate that the phenotypic overlap between AFD Nager
syndrome and MFDM is probably due in part to a shared
defect in the same biological process and suggests that
similar clinical phenotypes for which the cause has yet to
be identified might be due to variants in genes that have
a similar role.Supplemental Data
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edgments and can be found with this article online at http://www.
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